On Friday, Bicara Therapeutics Inc (NASDAQ: BCAX) opened higher 9.44% from the last session, before settling in for the closing price of $10.7. Price fluctuations for BCAX have ranged from $7.80 to $28.09 over the past 52 weeks.
Company’s average yearly earnings per share was noted 43.65% at the time writing. With a float of $30.93 million, this company’s outstanding shares have now reached $54.56 million.
Bicara Therapeutics Inc (BCAX) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Bicara Therapeutics Inc is 43.30%, while institutional ownership is 64.10%. The most recent insider transaction that took place on Sep 15 ’25, was worth 181,875. In this transaction Chief Legal Officer of this company sold 15,829 shares at a rate of $11.49, taking the stock ownership to the 0 shares. Before that another transaction happened on Jun 16 ’25, when Company’s Chief Legal Officer sold 15,829 for $10.43, making the entire transaction worth $165,096. This insider now owns 0 shares in total.
Bicara Therapeutics Inc (BCAX) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -1.6 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.5) by -1.1. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.54 per share during the current fiscal year. According to the Wall Street analysts, stocks earnings will be around 43.65% per share during the next fiscal year.
Bicara Therapeutics Inc (NASDAQ: BCAX) Trading Performance Indicators
Check out the current performance indicators for Bicara Therapeutics Inc (BCAX). In the past quarter, the stock posted a quick ratio of 25.80.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.89, a number that is poised to hit -0.54 in the next quarter and is forecasted to reach -2.62 in one year’s time.
Technical Analysis of Bicara Therapeutics Inc (BCAX)
Analysing the last 5-days average volume posted by the [Bicara Therapeutics Inc, BCAX], we can find that recorded value of 0.48 million was lower than the volume posted last year of 0.57 million. As of the previous 9 days, the stock’s Stochastic %D was 50.52%.
During the past 100 days, Bicara Therapeutics Inc’s (BCAX) raw stochastic average was set at 49.06%, which indicates a significant decrease from 62.75% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.62 in the past 14 days, which was lower than the 0.84 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.37, while its 200-day Moving Average is $12.57. Now, the first resistance to watch is $12.44. This is followed by the second major resistance level at $13.17. The third major resistance level sits at $14.15. If the price goes on to break the first support level at $10.73, it is likely to go to the next support level at $9.75. Now, if the price goes above the second support level, the third support stands at $9.02.
Bicara Therapeutics Inc (NASDAQ: BCAX) Key Stats
There are currently 54,563K shares outstanding in the company with a market cap of 638.93 million. Presently, the company’s annual sales total 0 K according to its annual income of -68,000 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -27,390 K.
